The aim of this study was to investigate the diagnostic accuracy and impact on patient
management of the new integrated PET/CT modality in patients with suspected iodine …

Abstract Purpose 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a
well-established method in the follow-up of patients with differentiated thyroid carcinoma …

Abstract The usefulness of combined 2-[18 F] fluoro-2-deoxy-D-glucose positron emission
tomography and computed tomography (FDG-PET/CT) in locating suspected recurrence in …

Purpose To evaluate the diagnostic potential of PET/MRI with [18 F] FDG in comparison to
PET/CT in patients with differentiated thyroid cancer suspected or known to have …

The aim of this study is to evaluate the clinical significance of 124 I positron emission
tomography (PET) using a combined PET/CT tomograph in patients with differentiated …

Aim The aim of this study was to evaluate the diagnostic accuracy of 18 F-
fluorodeoxyglucose-PET (FDG-PET) and FDG-PET/computed tomography (CT) in the …

In patients affected by differentiated thyroid cancer (DTC), the lacking of 131Iodine trapping
by metastatic tissue does not allow 131Iodine whole body scintigraphy to visualize …

The primary clinical application of 18 F FDG PET/CT (18 Fluorine labeled flurodeoxyglucose
positron emission tomography/computed tomography) in differentiated thyroid carcinoma is …

A more conservative approach to the clinical management of thyroid nodules and
differentiated thyroid cancer has recently been proposed by the 2015 ATA guidelines. In this …

The standard treatment of differentiated thyroid cancer (DTC) consists of surgery followed by
iodine-131 (131 I) administration. Although the majority of DTC has a very good prognosis …